Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Danny Dhanasekaran and Muralidharan Jayaraman.
Danny Dhanasekaran
Connection Strength
4.054
Muralidharan Jayaraman
  1. Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer. Genes Cancer. 2017 May; 8(5-6):566-576.
    View in: PubMed
    Score: 0.585
  2. Engineered Saccharomyces cerevisiae strain BioS-OS1/2, for the detection of oxidative stress. Biotechnol Prog. 2005 Sep-Oct; 21(5):1373-9.
    View in: PubMed
    Score: 0.261
  3. Optimizing lncRNA-miRNA interaction analysis: Modified crosslinking and immunoprecipitation (M-CLIP) assay. MethodsX. 2024 Dec; 13:103028.
    View in: PubMed
    Score: 0.246
  4. Deciphering a GPCR-lncrna-miRNA nexus: Identification of an aberrant therapeutic target in ovarian cancer. Cancer Lett. 2024 Jun 01; 591:216891.
    View in: PubMed
    Score: 0.237
  5. Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies. Metabolites. 2023 Apr 30; 13(5).
    View in: PubMed
    Score: 0.222
  6. Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis. Biomark Insights. 2022; 17:11772719221088404.
    View in: PubMed
    Score: 0.206
  7. Unraveling Autocrine Signaling Pathways through Metabolic Fingerprinting in Serous Ovarian Cancer Cells. Biomedicines. 2021 Dec 16; 9(12).
    View in: PubMed
    Score: 0.202
  8. GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer. Biomolecules. 2021 08 14; 11(8).
    View in: PubMed
    Score: 0.197
  9. Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer. Oncol Lett. 2021 Oct; 22(4):719.
    View in: PubMed
    Score: 0.197
  10. Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets. J Cancer Prev. 2020 Sep 30; 25(3):136-151.
    View in: PubMed
    Score: 0.185
  11. Differential effects of thymoquinone on lysophosphatidic acid-induced oncogenic pathways in ovarian cancer cells. J Tradit Complement Med. 2020 May; 10(3):207-216.
    View in: PubMed
    Score: 0.180
  12. Ovarian cancer cell-derived lysophosphatidic acid induces glycolytic shift and cancer-associated fibroblast-phenotype in normal and peritumoral fibroblasts. Cancer Lett. 2019 02 01; 442:464-474.
    View in: PubMed
    Score: 0.163
  13. LPA Induces Metabolic Reprogramming in Ovarian Cancer via a Pseudohypoxic Response. Cancer Res. 2018 04 15; 78(8):1923-1934.
    View in: PubMed
    Score: 0.154
  14. Aberrant expression of JNK-associated leucine-zipper protein, JLP, promotes accelerated growth of ovarian cancer. Oncotarget. 2016 Nov 08; 7(45):72845-72859.
    View in: PubMed
    Score: 0.142
  15. Lysophosphatidic acid stimulates epithelial to mesenchymal transition marker Slug/Snail2 in ovarian cancer cells via Gai2, Src, and HIF1a signaling nexus. Oncotarget. 2016 Jun 21; 7(25):37664-37679.
    View in: PubMed
    Score: 0.138
  16. Determinant role for the gep oncogenes, Ga12/13, in ovarian cancer cell proliferation and xenograft tumor growth. Genes Cancer. 2015 Jul; 6(7-8):356-364.
    View in: PubMed
    Score: 0.129
  17. LPA-mediated migration of ovarian cancer cells involves translocalization of Gai2 to invadopodia and association with Src and ß-pix. Cancer Lett. 2015 Jan 28; 356(2 Pt B):382-91.
    View in: PubMed
    Score: 0.123
  18. The gep proto-oncogene Ga13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells. Pancreas. 2013 Jul; 42(5):819-28.
    View in: PubMed
    Score: 0.112
  19. Lysophosphatidic Acid Stimulates the Proliferation of Ovarian Cancer Cells via the gep Proto-Oncogene Ga(12). Genes Cancer. 2011 May; 2(5):563-75.
    View in: PubMed
    Score: 0.097
  20. Heterologous expression of olfactory receptors for targeted chemosensing. Ann N Y Acad Sci. 2009 Jul; 1170:157-60.
    View in: PubMed
    Score: 0.085
  21. Chemical sensing of DNT by engineered olfactory yeast strain. Nat Chem Biol. 2007 Jun; 3(6):325-30.
    View in: PubMed
    Score: 0.073
  22. Transition from androgenic to neurosteroidal action of 5a-androstane-3a, 17ß-diol through the type A ?-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2018 04; 178:89-98.
    View in: PubMed
    Score: 0.038
  23. MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
    View in: PubMed
    Score: 0.037
  24. Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol. 2012 May; 82(2):116-40.
    View in: PubMed
    Score: 0.024
  25. G(alpha)12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulation. Carcinogenesis. 2010 Jul; 31(7):1230-7.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.